
PASSAGE BIO INC
PASGNASDAQ๐ #3637 by market capEarnings Nov 9US Equity
$4.50โฒ $0.19 (+4.17%)
๐ After hours$4.50โฒ 0.00%Regular close ยท extended-hours price shown1hโ
24hโฒ 4.2%
7dโ
14dโ
30dโ
1yโ
๐ฆMarket Cap
$14M
Small Cap
๐Revenue Growth (YoY)
โ
๐Gross Margin
โ
๐ตFCF Margin
โ
โ๏ธP/S Ratio
โ
Otter Score
61
Fair
๐
Analyst Ratings
Price
$4.50
Total
11
Raised
0
Lowered
5
Avg PT
$10.00
H / L
$15 / $7
| Institution | Action | Rating | Date |
|---|---|---|---|
TD Cowen | Downgraded | Buy โ Hold | 2026-04-21 |
Chardan Capital | Downgraded | Buy โ Neutral | 2026-04-21 |
Oppenheimer | Reiterated | Outperform | 2026-04-21 |
Wedbush | Downgraded | Outperform โ Neutral | 2026-04-21 |
Canaccord Genuity | Reiterated | Buy | 2026-03-04 |
Guggenheim | Reiterated | Buy | 2025-08-14 |
Raymond James | Reiterated | Outperform | 2023-11-14 |
Citigroup | Reiterated | Buy | 2022-11-11 |
JP Morgan | Downgraded | Overweight โ Neutral | 2022-03-08 |
Goldman Sachs | Downgraded | Buy โ Neutral | 2022-01-19 |
BTIG | Reiterated | Buy | 2021-06-15 |
One row per institution, most recent rating